Diagnosis and treatment of childhood mitochondrial diseases

Current Neurology and Neuroscience Reports

Volumn 1, Issue 2, 2001, Pages 185-194

  Gropman, Andrea L ^a  

^a NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

Author keywords

Idebenone; Lactic Acidosis; Mitochondrial Disease; Mitochondrial Disorder; Myoclonic Epilepsy

Indexed keywords

BIOLOGICAL MARKER; CYTOCHROME C OXIDASE; DNA; MITOCHONDRIAL DNA;

BIOPSY; CHILD; CLASSIFICATION; CYTOCHROME C OXIDASE DEFICIENCY; DIET THERAPY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DNA REPLICATION; ELECTROENCEPHALOGRAPHY; ELECTRON TRANSPORT; ENERGY METABOLISM; ENZYMOLOGY; GENE DELETION; GENETIC COUNSELING; GENETICS; HUMAN; INFANT; LEBER HEREDITARY OPTIC NEUROPATHY; LEIGH DISEASE; MELAS SYNDROME; METABOLISM; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEOTIDE SEQUENCE; OXIDATIVE PHOSPHORYLATION; PATHOLOGY; POINT MUTATION; PRESCHOOL CHILD; PROTEIN SYNTHESIS; REVIEW; SKELETAL MUSCLE; SYNDROME;

BIOLOGICAL MARKERS; BIOPSY; CHILD; CHILD, PRESCHOOL; CYTOCHROME-C OXIDASE DEFICIENCY; DNA; DNA MUTATIONAL ANALYSIS; DNA REPLICATION; DNA, MITOCHONDRIAL; ELECTROENCEPHALOGRAPHY; ELECTRON TRANSPORT; ELECTRON TRANSPORT COMPLEX IV; ENERGY METABOLISM; GENETIC COUNSELING; HUMANS; INFANT; LEIGH DISEASE; MAGNETIC RESONANCE IMAGING; MELAS SYNDROME; MITOCHONDRIAL DISEASES; MUSCLE, SKELETAL; OPTIC ATROPHY, HEREDITARY, LEBER; OXIDATIVE PHOSPHORYLATION; POINT MUTATION; PROTEIN BIOSYNTHESIS; SEQUENCE DELETION; SYNDROME;

EID: 0035295967     PISSN: 15284042     EISSN: 15346293     Source Type: Journal    
DOI: 10.1007/s11910-001-0015-9     Document Type: Article

References (50)

1. Pollitt RJ, ed.: J Inherit Metab Dis 1996, 19:432–587.
2. Moraes CT: Mitochondrial disorders. Curr Opin Neurol 1996, 9:369–374. DOI: 10.1097/00019052-199610000-00010
3. Munnich A, Rotig A, Chretien D, Saudubray JM, et al.: Clinical presentations and laboratory investigations in respiratory chain deficiency. Eur J Pediatr 1996, 155:262–274. DOI: 10.1007/BF02002711
4. Simon DK, Johns DR: Mitochondrial disorders: clinical presentations and laboratory investigations in respiratory chain deficiency. Ann Rev Med 1999, 50:111–127. DOI: 10.1146/annurev.med.50.1.111
5. Shoffner JM, Wallace DC: Oxidative phosphorylation diseases. In The Metabolic and Molecular Bases of Inherited Disease. Edited by Scriver CR, Beaudet Al, Sly WS, et al. New York: McGraw Hill; 1995:1535–1610.
6. Holt IJ, Harding AE, Morgan-Hughes JA: Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies. Nature 1988, 331:717–719. DOI: 10.1038/331717a0
7. Wallace DC, Singh G, Lott MT, et al.: Mitochondrial DNA mutation associated with Leber’s hereditary optic neuropathy. Science 1988, 242:1427–1430. DOI: 10.1126/science.3201231
8. Shoffner JM: Oxidative phosphorylation disease diagnosis. Semin Neurol 1999, 19:341–351. A complete summary of mitochondrial genetics, clinical presentations, and the laboratory and histopathologic diagnosis. DOI: 10.1055/s-2008-1040849
9. Johns DR: The other human genome: mitochondrial DNA and disease. Nat Med 1996, 2:1065–1068. DOI: 10.1038/nm1096-1065
10. Anderson S, Bankier AT, Barrell BG, et al.: Sequence and organization of the human mitochondrial genome. Nature 1981, 290:457–465. DOI: 10.1038/290457a0
11. Hayashi JI, Ohta S, Kikuchi A, et al.: Introduction of disease related mitochondrial DNA deletions into HeLa cells lacking mitochondrial DNA results in mitochondrial dysfunction. Proc Natl Acad Sci USA 1991, 88:10614–10618. DOI: 10.1073/pnas.88.23.10614
12. Hammans SR, Sweeney MG, Brockington M, et al.: The mitochondrial DNA transfer RNA (lys)A->G(8344) mutations and the syndrome of myoclonic epilepsy with ragged red fibers (MERRF): relationship of clinical phenotype to proportion of mutant mitochondrial DNA. Brain 1993, 116:617–632. DOI: 10.1093/brain/116.3.617
13. Leonard JV, Schapira AHV: Mitochondrial respiratory chain disorders II: neurodegenerative disorders and nuclear gene defects. Lancet 2000, 355:389–394. DOI: 10.1016/S0140-6736(99)05226-5
14. Bardosi A, Creutzfeldt W, DiMauro S, et al.: Myo-, neuro-, gastrointestinal encephalopathy (MNGIE syndrome) due to partial deficiency of cytochrome-c-oxidase: a new mitochondrial multisystem disorder. Acta Neuropathol 1987, 74:248–258. DOI: 10.1007/BF00688189
15. Hirano M, Garcia-de-Yebenes J, Jones AC, et al.: Mitochondrial neurogastrointestinal encephalomyopathy syndrome maps to chromosome 22q13.32-qter. Am J Hum Genet 1998, 63:526–533. DOI: 10.1086/301979
16. Hirano M, Silvestri G, Blake DM, et al.: Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): clinical, biochemical, and genetic features of an autosomal recessive mitochondrial disorder. Neurology 1994, 44:721–727.
17. Nishino I, Spinazzola A, Hirano M: Thymidine phosphorylase gene mutations in MNGIE: a human mitochondrial disorder. Science 1999, 283:689–692. DOI: 10.1126/science.283.5402.689
18. DiMauro S, De Vivo D: Genetic heterogeneity in Leigh syndrome. Ann Neurol 1996, 40:5–6. DOI: 10.1002/ana.410400104
19. Leigh D: Subacute necrotizing encephalomyelopathy in an infant. J Neurol Neurosurg Psychiatry 1951, 14:216–221.
20. Sparaco M, Bonilla E, DiMauro S, Powers T: Neuropathology of mitochondrial encephalomyopathies due to mitochondrial DNA defects. J Neuropathol Exp Neurol 1993, 52:1–10. DOI: 10.1097/00005072-199301000-00001
21. Tiranti V, Hoertnagel K, Carrozzo R, et al.: Mutations of SURF-1 in Leigh disease associated with cytochrome c oxidase deficiency. Am J Hum Genet 1998, 63:1609–1621. This report describes the use of linkage analysis leading to the identification of the Surf-1 gene, which encodes a mitochondrial protein necessary for maintanence of cytochrome-c-oxidase (COX) activity and is responsible for some cases of Leigh syndrome, by showing mutations in this gene from patient samples. DOI: 10.1086/302150
22. Loeffen J, Smeitink J, Triepels R, et al.: The first nuclear encoded complex I mutation in a patient with Leigh syndrome. Am J Hum Genet 1998, 63:1598–1608. This research report establishes the first molecular genetic link between a nuclear encoded subunit of complex I and Leigh Syndrome. DOI: 10.1086/302154
23. Jun AS, Brown MD, Wallace DC: A mitochondrial DNA mutation at np 14459 of the ND6 gene associated with maternally inherited Leber’s hereditary optic neuropathy and dystonia. Proc Natl Acad Sci USA 1994, 91:6206–6210. DOI: 10.1073/pnas.91.13.6206
24. Wallace DC, Singh G, Lott MT, et al.: Mitochondrial DNA mutation associated with Leber’s hereditary optic neuropathy. Science 1988, 242:1427–1430. DOI: 10.1126/science.3201231
25. Pavlakis SG, Phillips PC, DiMauro S, et al.: Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes: a distinctive clinical syndrome. Ann Neurol 1984, 16:481–488. DOI: 10.1002/ana.410160409
26. Shoffner JM, Lott MT, Lezza AMS, et al.: Myoclonic epilepsy and ragged-red fiber disease (MERRF) is associated with a mitochondrial DNA tRNA-lys mutation. Cell 1990, 61:931–937. DOI: 10.1016/0092-8674(90)90059-N
27. Holt IJ, Harding AE, Petty RKH, Morgan-Hughes JA: A new mitochondrial disease associated with mitochondrial DNA heteroplasmy. Am J Hum Genet 1990, 46:428–433.
28. Vu TH, Sciacco M, Tanji K, et al.: Clinical manifestations of mitochondrial DNA depletion. Neurology 1998, 50:1783–1790. This paper describes the clinical features of mitochondrial disorders due to low copy number of mitochondrial DNA.
29. Moraes CT, Shanske S, Tritschler HJ, et al.: MtDNA depletion with variable tissue expression: a novel genetic abnormality in mitochondrial diseases. Am J Hum Genet 1991, 48:492–501.
30. Larsson NC, Oldfors A, Holme E, Clayton DA: Low levels of mitochondrial transcription factor A in mitochondrial DNA depletion. Biochem Biophys Res Commun 1994, 200:1374–1381. DOI: 10.1006/bbrc.1994.1603
31. Bay CA, Del Vecchio MA, Matika GL: Mitochondrial diseases: a recognizable pattern of systemic disease [abstract]. Am J Hum Genet 1999, 65:141. DOI: 10.1086/302461
32. Tanji K, Vu TH, Schon EA, et al.: Kearns-Sayre Syndrome: unusual pattern of expression of subunits of the respiratory chain in the cerebellar system. Ann Neurol 1999, 45:377–383. DOI: 10.1002/1531-8249(199903)45:3<377::AID-ANA14>3.0.CO;2-M
33. Matthews PM, Taivassalo T: Applications of magnetic resonance spectroscopy for diagnosis and monitoring of mitochondrial disease. Ital J Neurol Sci 1997, 18:341–351. DOI: 10.1007/BF02048237
34. Valanne L, Ketonen L, Majander A, et al.: Neuroradiologic findings in children with mitochondrial disorders. AJNR 1998, 19:369–377.
35. Munoz A, Mateos F, Simon R, et al.: Mitochondrial diseases in children: neuroradiologic and clinical features in 17 patients. Neuroradiology 1999, 41:920–928. An interesting report that describes the various MRI findings in children with mitochondrial disease. DOI: 10.1007/s002340050868
36. deLonlay-Debeney P, von Kleist-Retzow JC, Hertz-Pannier L, et al.: Cerebral white matter disease in children may be caused by mitochondrial respiratory chain deficiency. J Pediatr 2000, 136:209–214. DOI: 10.1016/S0022-3476(00)70103-X
37. Harpey JP, Heron D, Prudent M, Charpentier C, et al.: Diffuse leukodystrophy in an infant with cytochrome C oxidase deficiency. J Inherit Metab Dis 1998, 21:748–752. DOI: 10.1023/A:1005497116398
38. Rahman S, Lake BD, Taanman JW, et al.: Cytochrome oxidase immunohistochemistry: clues for genetic mechanisms. Brain 2000, 123:591–600. DOI: 10.1093/brain/123.3.591
39. Liechti-Gallati S, Schneider V, Neeser D, Kraemer R: Two buffer PAGE system based SSCP/HD analysis: a general protocol for rapid and sensitive mutation screening in cystic fibrosis and any other human genetic disease. Eur J Hum Genet 1999, 7:590–598. DOI: 10.1038/sj.ejhg.5200338
40. Chen TJ, Boles RG, Wong LJC: Detection of mitochondrial DNA mutations by temporal temperature gradient gel electrophoresis. Clin Chem 1999, 45:1161–1167.
41. Wexler ID, Hemalatha SG, McConnell J, et al.: Outcome of pyruvate dehydrogenase deficiency treated with ketogenic diets. Studies in patients with identical mutations. Neurology 1997, 49:1655–1661.
42. Taivassalo T, De Stefano N, Argov Z, et al.: Effects of aerobic training in patients with mitochondrial myopathies. Neurology 1998, 50:1055–1060.
43. Chen RS, Huang CC, Chu NS: Coenzyme Q10 treatment in mitochondrial encephalomyopathies. Short-term double-blind, crossover study. Eur Neurol 1997, 37:212–218.
44. Walker UA, Byrne E: The therapy of respiratory chain encephalomyopathy: a critical review of the past and present perspective. Acta Neurol Scand 1995, 92:273–280. DOI: 10.1111/j.1600-0404.1995.tb00130.x
45. Tarnopolsky MA, Roy BD, MacDonald JR: A randomized, controlled trial of creatine monohydrate in patients with mitochondrial cytopathies. Muscle Nerve 1997, 20:1502–1509. DOI: 10.1002/(SICI)1097-4598(199712)20:12<1502::AID-MUS4>3.0.CO;2-C
46. Ernster L, Dallner G: Biochemical, physiological and medical aspects of ubiquinone function. Biochim Biophys Acta 1995, 1271:195–204.
47. Stacpoole PW: The pharmacology of dichloroacetate. Metabolism 1989, 38:1124–1144. DOI: 10.1016/0026-0495(89)90051-6
48. De Stefano N, Matthews PM, Ford B, et al.: Short-term dichloroacetate treatment improves indices of cerebral metabolism in patients with mitochondrial disorders. Neurology 1995, 45:1193–1198.
49. Saitoh S, Momoi MY, Yamagata T, et al.: Effects of dichloroacetate in three patients with MELAS. Neurology 1998, 50:531–534.
50. Rustin P, von Kleist-Retzow JC, Chantrel-Groussard K, et al.: Effect of idebenone on cardiomyopathy in Friedreich’s ataxia: a preliminary study. Lancet 1999, 354:477–479. DOI: 10.1016/S0140-6736(99)01341-0